VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS42001416 | EBV | ENSG00000169684.13 | protein_coding | CHRNA5 | No | No | 1138 | H0YM98 P30532 Q6EWN4 |
TVIS10020737 | HBV | ENSG00000169684.13 | protein_coding | CHRNA5 | No | No | 1138 | H0YM98 P30532 Q6EWN4 |
TVIS10046153 | HBV | ENSG00000169684.13 | protein_coding | CHRNA5 | No | No | 1138 | H0YM98 P30532 Q6EWN4 |
TVIS30010369 | HIV | ENSG00000169684.13 | protein_coding | CHRNA5 | No | No | 1138 | H0YM98 P30532 Q6EWN4 |
TVIS30039126 | HIV | ENSG00000169684.13 | protein_coding | CHRNA5 | No | No | 1138 | H0YM98 P30532 Q6EWN4 |
TVIS30039127 | HIV | ENSG00000169684.13 | protein_coding | CHRNA5 | No | No | 1138 | H0YM98 P30532 Q6EWN4 |
TVIS30039128 | HIV | ENSG00000169684.13 | protein_coding | CHRNA5 | No | No | 1138 | H0YM98 P30532 Q6EWN4 |
TVIS44051140 | HTLV-1 | ENSG00000169684.13 | protein_coding | CHRNA5 | No | No | 1138 | H0YM98 P30532 Q6EWN4 |
TVIS44047313 | HTLV-1 | ENSG00000169684.13 | protein_coding | CHRNA5 | No | No | 1138 | H0YM98 P30532 Q6EWN4 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | CHRNA5 |
---|---|
DrugBank ID | DB00184 |
Drug Name | Nicotine |
Target ID | BE0003586 |
UniProt ID | P30532 |
Regulation Type | agonist |
PubMed IDs | 19560048; 11006350; 20400469; 20081230 |
Citations | Mansvelder HD, Mertz M, Role LW: Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits. Semin Cell Dev Biol. 2009 Jun;20(4):432-40. doi: 10.1016/j.semcdb.2009.01.007. Epub 2009 Jan 22.@@Narahashi T, Fenster CP, Quick MW, Lester RA, Marszalec W, Aistrup GL, Sattelle DB, Martin BR, Levin ED: Symposium overview: mechanism of action of nicotine on neuronal acetylcholine receptors, from molecule to behavior. Toxicol Sci. 2000 Oct;57(2):193-202.@@Jackson KJ, Marks MJ, Vann RE, Chen X, Gamage TF, Warner JA, Damaj MI: Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice. J Pharmacol Exp Ther. 2010 Jul;334(1):137-46. doi: 10.1124/jpet.110.165738. Epub 2010 Apr 16.@@Zaniewska M, Przegalinski E, Filip M: Nicotine dependence - human and animal studies, current pharmacotherapies and future perspectives. Pharmacol Rep. 2009 Nov-Dec;61(6):957-65. |
Groups | Approved |
Direct Classification | Pyrrolidinylpyridines |
SMILES | CN1CCC[C@H]1C1=CN=CC=C1 |
Pathways | Nicotine Action Pathway; Nicotine Metabolism Pathway |
PharmGKB | PA450626 |
ChEMBL | CHEMBL3 |